Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (21-30 of 203) with videos related to

Pageof 21
Sort By:
Scientific Reports|January 14, 2021
Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cellsTamara Heintze, Kathrin Klein, Ute Hofmann, et al.
Biochemical Pharmacology|May 9, 2000
Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugsK Kreth, K Kovar, M Schwab, et al.
Frontiers in Genetics|February 4, 2012
MIRNA-DISTILLER: A Stand-Alone Application to Compile microRNA Data from DatabasesJessica K Rieger, Denis A Bodan, Ulrich M Zanger
Archives of Biochemistry and Biophysics|August 20, 1995
Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregationA C Kempf, U M Zanger, U A Meyer
Biochemical Pharmacology|January 18, 2005
Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-basedTanja Richter, Matthias Schwab, Michel Eichelbaum, et al.
Pharmacology & Therapeutics|January 1, 1990
The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanismsU A Meyer, R C Skoda, U M Zanger
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1997
Functional properties of CYP2D6 1 (wild-type) and CYP2D6 7 (His324Pro) expressed by recombinant baculovirus in insect cellsB Evert, M Eichelbaum, H Haubruck, et al.
Analytical and Bioanalytical Chemistry|August 13, 2008
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformationUlrich M Zanger, Miia Turpeinen, Kathrin Klein, et al.
Chemistry & Biodiversity|November 26, 2009
RNA-interference approach to study functions of NADPH : cytochrome P450 oxidoreductase in human hepatocytesDiana M Feidt, Kathrin Klein, Andreas Nüssler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2013
Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: influence of nongenetic factors and association with gene expressionJessica K Rieger, Kathrin Klein, Stefan Winter, et al.
Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Scientific Reports|January 14, 2021
Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cellsTamara Heintze, Kathrin Klein, Ute Hofmann, et al.
Biochemical Pharmacology|May 9, 2000
Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugsK Kreth, K Kovar, M Schwab, et al.
Frontiers in Genetics|February 4, 2012
MIRNA-DISTILLER: A Stand-Alone Application to Compile microRNA Data from DatabasesJessica K Rieger, Denis A Bodan, Ulrich M Zanger
Archives of Biochemistry and Biophysics|August 20, 1995
Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregationA C Kempf, U M Zanger, U A Meyer
Biochemical Pharmacology|January 18, 2005
Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-basedTanja Richter, Matthias Schwab, Michel Eichelbaum, et al.
Pharmacology & Therapeutics|January 1, 1990
The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanismsU A Meyer, R C Skoda, U M Zanger
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1997
Functional properties of CYP2D6 1 (wild-type) and CYP2D6 7 (His324Pro) expressed by recombinant baculovirus in insect cellsB Evert, M Eichelbaum, H Haubruck, et al.
Analytical and Bioanalytical Chemistry|August 13, 2008
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformationUlrich M Zanger, Miia Turpeinen, Kathrin Klein, et al.
Chemistry & Biodiversity|November 26, 2009
RNA-interference approach to study functions of NADPH : cytochrome P450 oxidoreductase in human hepatocytesDiana M Feidt, Kathrin Klein, Andreas Nüssler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2013
Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: influence of nongenetic factors and association with gene expressionJessica K Rieger, Kathrin Klein, Stefan Winter, et al.
Pageof 21